The consumer genomics space has been rife with concerns about data ownership, usage, privacy, and security. From companies getting hacked to ones profiting from consumer data without notice or compensation, consumers have become more concerned about having their genomes sequenced. This unfortunately means that pharmaceutical developers face limited access to large genomic datasets, which is critical for the development of targeted treatments. Nebula Genomics offers a solution that resolves the matter for both parties (consumers and companies) by building a marketplace around genomic data on a blockchain platform. Merck Serono plans to leverage Nebula's platform to develop personalized lung cancer treatments in this recently announced partnership.
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)